Mg Biologics C. Perfringens A R. Equi Plasma 1100 Injectable

Hyperimmune equine plasma (Clostridium perfringens/Rhodococcus equi) for passive immunization of neonatal foals at risk for septicemia and failure of passive transfer. Equine hyperimmune plasma (C. perfringens A + R. equi). Mechanism: plasma from horses hyperimmunized against Clostridium perfringens Type A and Rhodococcus equi contains high-titer specific antibodies (IgG) → passive immunization of foals via IV transfusion → immediate protection while foal develops active immunity. Key information Hyperimmune equine plasma. Refrigerate; check expiry. Warm to room temperature before IV infusion. Use IV set with filter. Monitor for transfusion reactions.

IV infusion: administer via jugular catheter slowly using blood administration set with filter. Have epinephrine available. Monitor throughout infusion. Store refrigerated (2–8°C); do not freeze. If a dose is missed This medication is administered by a veterinarian or veterinary staff in a clinical setting. Missed doses are managed by your veterinary team — contact your veterinarian to reschedule.

Transfusion reactions: fever, urticaria, hemolysis. Volume overload (neonatal foals — give slowly). Rare: anaphylaxis. Disease transmission minimized with screened donors.

For animals Administer IV slowly — monitor for transfusion reactions. Volume limits for neonatal foals. Have epinephrine available. For people handling this medication Administered by veterinary professionals only. No specific human precautions for caregivers beyond normal hygiene.

Contact your veterinarian. Plasma transfusion reactions are managed by veterinary staff.